down arrow

Kovai Medical

  • Market Cap: Mid Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE177F01017
  • NSEID: KOVAI
  • BSEID: 523323
INR
5,493.65
143.65 (2.69%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.52 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

5,405.005,500.00

52 Week

3,750.006,400.00
Valuation
Technical
Day's Volume

CASH

8.52 k (-2.67%) Volume

Shareholding (Dec 2024)

FII

0.56%

Held by 40 FIIs

DII

4.43%

Held by 4 DIIs

Promoter

56.55%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROCE of 18.25%

 
2

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.36 times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 14.04% and Operating profit at 18.22% over the last 5 years

 
4

Flat results in Dec 24

5

Technical trend is Sideways signifying no clear price momentum

6

With ROE of 23.2, it has a Very Attractive valuation with a 6.6 Price to Book Value

7

Majority shareholders : Promoters

 
8

Consistent Returns over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 6,011 Cr (Mid Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.19%

stock-summary
Debt Equity

0.07

stock-summary
Return on Equity

23.23%

stock-summary
Price to Book

6.59

Revenue and Profits (1 Year):
Net Sales:
355 Cr
(Quarterly Results - Dec 2024)
Net Profit:
58 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.19%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
1.08%
0%
1.08%
1 Year
36.77%
0.25%
37.02%
2 Years
188.47%
0.75%
189.22%
3 Years
222.18%
1.26%
223.44%
4 Years
372.08%
1.62%
373.7%
5 Years
785.14%
3.65%
788.79%

Latest dividend: 10 per share ex-dividend date: Aug-01-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
14.04%
EBIT Growth (5y)
18.22%
EBIT to Interest (avg)
5.53
Debt to EBITDA (avg)
1.88
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.12
Tax Ratio
23.59%
Dividend Payout Ratio
6.09%
Pledged Shares
0
Institutional Holding
4.98%
ROCE (avg)
24.06%
ROE (avg)
18.12%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
55
Price to Book Value
6.59
EV to EBIT
21.15
EV to EBITDA
15.72
EV to Capital Employed
6.22
EV to Sales
4.43
PEG Ratio
0.92
Dividend Yield
0.19%
ROCE (Latest)
21.32%
ROE (Latest)
23.23%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 6 Schemes (3.99%)

FIIs

Held by 40 FIIs (0.56%)

Promoter with highest holding

Kovai Purani Finance Private Limited (36.96%)

Highest Public shareholder

Quant Mutual Fund - Quant Value Fund (1.61%)

Individual Investors Holdings

22.3%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 3.22% vs 9.18% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 14.03% vs 10.80% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "354.70",
          "val2": "343.65",
          "chgp": "3.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "102.90",
          "val2": "95.50",
          "chgp": "7.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.16",
          "val2": "8.24",
          "chgp": "11.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "57.80",
          "val2": "50.69",
          "chgp": "14.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.01%",
          "val2": "27.79%",
          "chgp": "1.22%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 14.17% vs 18.16% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 29.52% vs 37.71% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "658.41",
          "val2": "576.70",
          "chgp": "14.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "181.77",
          "val2": "153.68",
          "chgp": "18.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.87",
          "val2": "18.71",
          "chgp": "-20.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "96.44",
          "val2": "74.46",
          "chgp": "29.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.61%",
          "val2": "26.65%",
          "chgp": "0.96%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 12.88% vs 19.31% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 20.92% vs 49.70% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,013.11",
          "val2": "897.49",
          "chgp": "12.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "284.67",
          "val2": "250.02",
          "chgp": "13.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "24.03",
          "val2": "26.05",
          "chgp": "-7.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "154.24",
          "val2": "127.56",
          "chgp": "20.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.07%",
          "val2": "27.83%",
          "chgp": "0.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 19.61% vs 12.62% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 55.25% vs 11.04% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,218.27",
          "val2": "1,018.56",
          "chgp": "19.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "341.69",
          "val2": "268.52",
          "chgp": "27.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "32.94",
          "val2": "40.16",
          "chgp": "-17.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "179.73",
          "val2": "115.77",
          "chgp": "55.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.05%",
          "val2": "26.36%",
          "chgp": "1.69%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
354.70
343.65
3.22%
Operating Profit (PBDIT) excl Other Income
102.90
95.50
7.75%
Interest
9.16
8.24
11.17%
Exceptional Items
0.00
0.00
Standalone Net Profit
57.80
50.69
14.03%
Operating Profit Margin (Excl OI)
29.01%
27.79%
1.22%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 3.22% vs 9.18% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 14.03% vs 10.80% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
658.41
576.70
14.17%
Operating Profit (PBDIT) excl Other Income
181.77
153.68
18.28%
Interest
14.87
18.71
-20.52%
Exceptional Items
0.00
0.00
Standalone Net Profit
96.44
74.46
29.52%
Operating Profit Margin (Excl OI)
27.61%
26.65%
0.96%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 14.17% vs 18.16% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 29.52% vs 37.71% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,013.11
897.49
12.88%
Operating Profit (PBDIT) excl Other Income
284.67
250.02
13.86%
Interest
24.03
26.05
-7.75%
Exceptional Items
0.00
0.00
Standalone Net Profit
154.24
127.56
20.92%
Operating Profit Margin (Excl OI)
28.07%
27.83%
0.24%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 12.88% vs 19.31% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 20.92% vs 49.70% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,218.27
1,018.56
19.61%
Operating Profit (PBDIT) excl Other Income
341.69
268.52
27.25%
Interest
32.94
40.16
-17.98%
Exceptional Items
0.00
0.00
Standalone Net Profit
179.73
115.77
55.25%
Operating Profit Margin (Excl OI)
28.05%
26.36%
1.69%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 19.61% vs 12.62% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 55.25% vs 11.04% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Kovai Medical Center & Hospital Ltd stock-summary
stock-summary
Kovai Medical Center & Hospital Ltd
Mid Cap
Hospital & Healthcare Services
Kovai Medical Center and Hospital Limited was incorporated as a Public Company in year 1985 and commenced its hospital operation in year 1990 with the flagship of Multi-Speciality Hospital at Coimbatore with a capacity of 200 Bed Hospital. Thereafter, the Hospital set up the satellite centers at Coimbatore in the name of City Center, Sulur Hospital and Kovilpalayam Hospital and Erode in the name of Erode Speciality Hospital.
Company Coordinates stock-summary
Company Details
99 Avanashi Road , Coimbatore Tamil Nadu : 641014
stock-summary
Tel: 91-422-4323800/3083800
stock-summary
http://www.kmchhospitals.com
stock-summary
secretarialdept@kmchhospitals.com/a
Registrar Details
GNSA Investor Services (P) Ltd , G R Mansion, 11 Srinivasan Road, Pondy Bazaar T Nagar , Chennai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."